Product Overview
You are here: Home » Professionals » Product Overview
A New Dimension in Catheter Ablation
Imagine an ablation catheter that allows electro-physiologists to know exactly how much contact force they are applying on cardiac tissues during the delicate catheter ablation procedure.
Endosense has met this challenge with the development of its TactiCath®, the first force-sensing ablation catheter to provide a real-time, objective measure of contact force between the catheter and the beating heart wall. Representing a dramatic leap forward in catheter ablation technology, TactiCath allows the electro-physiologist to deliver the right force for the right lesion.
A New Standard in Ablation Catheters
TactiCath is a high-end ablation catheter with features designed to have a major positive impact on physician ease of use, safety, effectiveness and efficiency, while optimizing the latest in mapping and robotic techniques.
Product Features
- Integrated with Touch+ fiber optic sensor technology
- Real-time and highly accurate tip-to-tissue contact force measurements
- Measurement and display of tip-to-tissue angles and orientation
- 3.5 mm open irrigated tip
- Shaft: 7 F, usable length 115 cm
- Tip electrode: 3.5 mm, open irrigated
- Electrode Spacing: 2-5-2 mm
- Curve Shape: D curve, 65 mm
Anticipated Benefits
- A major positive impact on the efficacy of lesion creation during AF ablation procedures
- Improved real-time decision-making, potentially shortening procedure times
- Improved safety of cardiac ablation procedures
- Simplified physician training
Endosense’s TactiCath ablation catheter has undergone extensive preclinical testing in the United States and Europe. The first human trial of TactiCath, TOCCATA (TOuCh+ in CATheter Ablation) was conducted in Europe in 2008 and 2009, with CE Mark approval in 2009. Clinical cases and further clinical studies took place in 2009, consolidating the evidence of the TactiCath’s clinical utility. TactiCath is currently not available in the United States.